» Download Public Reports
About 100 reports
- Company report
- November 2012
- 19 pages
... Region and only seven licenses have been authorized as of today. China cord blood corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage ...
September 2012
... And the number of new subscribers continuing to rise, the additional capital will pave the way for ccbc to seize market opportunities and bring premium cord blood banking services to even wider public in china ...
September 2012
... Authorised in the prc as of today. Ccbc provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cells storage services. Reasons for and benefits of the subscription ...
November 2012
... Strengthens our competitive position as a leading plasma-based biopharmaceutical company in china. Going forward, we intend to continue to develop and manufacture leading life-enhancing, quality ...
January 2013
... Immunoglobulin capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufactus human tetanus immunoglobulin products customers ...
February 2013
... Share of spend) it is a waste of money to buy it and give it to the sales reps (remember the white blood cells) how is their time invested in market serving versus market making Measure potential ...
October 2012
... Cell transplantation cost-effectiveness a cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in thailand leelahavarong et al ...
April 2013
... Of transfusions while ensuring each patient is looked at as an individual definitions of patient blood management percentage of hospital blood bankdirectors/managers conservative transfusion approach 20% evaluating ...
» Purchase Premium Reports
(From $ 250 - $ 2 648)
24 reports
- $ 2 732
- Industry report
- March 2013
- by Visiongain
Report Details Biobanks - what are their technological and commercial prospects? See what the future holds for biobanking in human medicine. Visiongain's updated report gives you its revenue predictions ...
March 2013
$ 800
Recent scientific studies are leading to the discovery of new proteins in the blood plasma and their uses to treat hitherto unresolved medical conditions. The industry for blood plasma products has shown ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
April 2013
$ 250
Summary China Cord Blood Corporation is engaged in providing cord blood storage services in China. The company provides cord blood storage services for expectant parents interested in capturing the opportunities ...